ANIEMEA-P-GB-202600235 | February 2026
Authors:
Dr Sanjay Suman, MD, FRCP
Publish Date:
April 2019 | 22 min
Abstract:
Sarcopenia is the age-related progressive loss of muscle mass, strength and function. It is a key contributor to the onset and exacerbation of frailty, increasing risk of falls, disability and poorer quality of life in older people.
Once you have watched this video, please remember to complete your self-reflective notes to contribute towards your continuing professional development. You will then be able to access your Certificate of Completion.
LEARNING OBJECTIVES
Understand the definition of sarcopenia.
Identify the relationship between sarcopenia, osteoporosis, and risk of falls.
Explain how to manage sarcopenia through nutrition and exercise.
AUTHOR(S) BIO
DR SANJAY SUMAN, MD, FRCP
Consultant Geriatrician & Clinical Director, Medway NHS Foundation Trust, Kent
Sanjay Suman is the Clinical Director of the Therapies and Older Persons Programme at Medway NHS Foundation Trust in Kent. He was appointed as Consultant Geriatrician in 2007 and is a Fellow of Royal College of Physicians, London. Sanjay has special interest in frailty, sarcopenia, falls and syncope in elderly patients and runs an orthogeriatric service for fracture neck of femur pathway at Medway NHS Foundation Trust.
In his clinical director role he has developed a number of bespoke frailty focused assessment pathways such as the acute frailty unit and falls and syncope clinic for elderly. In the community, he has supported the development of a number of services such as care home support services, geriatric led MDT meetings in the community to name a few. He has been a recipient of Academic Health Sciences Network (Kent, Sussex and Surrey) Leadership and Innovation award for excellence in out of hospital care category 2017.
As a subject matter expert, Sanjay has delivered a number of keynote lectures on frailty, sarcopenia, polypharmacy reduction and falls at national and international conferences. He is passionate about improving the reversible components of frailty, such as nutritional status and polypharmacy reduction, contributing to improving clinical outcomes for frail individuals, both in primary and secondary care.
